28
Feb
Offers Discounted Testing for Low-Income Patients Bengaluru: On the occasion of Rare Disease Day, Strand Life Sciences, a Reliance Industries subsidiary and leading genomics company, today launched the StrandOmics Portal to improve diagnosis of rare diseases. This new online portal gives clinicians quick and easy access to information on genetic variants, giving them a comprehensive view for each case. This means faster and more accurate diagnosis for patients. In addition to the portal, Strand Life Sciences will offer rare disease genetic testing at a reduced cost for patients from economically disadvantaged backgrounds, making these crucial tests more accessible. The StrandOmics…
